Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic control (Q38979407)

8 September 2017

Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic control (English)

1 reference

8 September 2017

Tongzhi Wu

1

1 reference

8 September 2017

Christopher K Rayner

series ordinal

2

1 reference

8 September 2017

Michael Horowitz

series ordinal

3

1 reference

8 September 2017

13 October 2016

1 reference

8 September 2017

Biomarkers in Medicine

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

8 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Factors Associated With Cardiovascular Events in Patients With Type 2 Diabetes and Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Relationships between gastric emptying, postprandial glycemia, and incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Relationships of Early And Late Glycemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Gut motility and enteroendocrine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Gastric emptying and glycaemia in health and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Gastric Emptying Is More Rapid in Adolescents With Type 1 Diabetes and Impacts on Postprandial Glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Relationship between clinical features and gastric emptying disturbances in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Predictors of delayed gastric emptying in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Sustained effects of a protein 'preload' on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: A randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2016-0164

21 January 2018

Identifiers

DOI

10.2217/BMM-2016-0164

0 references

1 reference